Stocks
Astellas Pharma Inc.ALPMY
OTCHealthcarePharmaceuticals$14.66-0.74%
A Japan-based pharmaceutical manufacturer focused on developing and commercializing prescription medicines across oncology, urology, immunology, and rare diseases. The company generates significant revenue from global therapies such as Xtandi for prostate cancer and continues to invest heavily in cl...
Market Cap: $26.3B52W Range: $8.37 – $16.95
This page tracks all publicly disclosed congressional trades in Astellas Pharma Inc. (ALPMY), a company in the Healthcare sector. 3 members of Congress have disclosed trades in this stock, including 8 purchases and 4 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
12
Unique Politicians
3
Buys
8
Sells
4
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $15K – $50K |
| 2023-02-27 | Daniel Goldman | buy | $15K – $50K |